ranbezolid has been researched along with Pneumococcal-Infections* in 1 studies
1 other study(ies) available for ranbezolid and Pneumococcal-Infections
Article | Year |
---|---|
Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.
For 260 pneumococcal and 266 staphylococcal strains, ranbezolid MICs ranged from < or =0.06 to 4 micro g/ml. The MICs for pneumococci were similar irrespective of the strains' beta-lactam, macrolide, or quinolone susceptibilities, and ranbezolid MICs for coagulase-negative staphylococci were lower than those for Staphylococcus aureus. Ranbezolid was bacteriostatic against pneumococci. Ranbezolid MICs were similar to or lower than those of linezolid. Vancomycin and quinupristin-dalfopristin were also very active. Topics: Anti-Bacterial Agents; Culture Media; Furans; Humans; Kinetics; Microbial Sensitivity Tests; Oxazoles; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus; Streptococcus pneumoniae | 2003 |